0001209191-14-022507.txt : 20140321 0001209191-14-022507.hdr.sgml : 20140321 20140321174306 ACCESSION NUMBER: 0001209191-14-022507 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140312 FILED AS OF DATE: 20140321 DATE AS OF CHANGE: 20140321 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Satellite Overseas (Holdings) Ltd CENTRAL INDEX KEY: 0001461647 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 14711351 BUSINESS ADDRESS: STREET 1: SARKHEJ-DHOLKA ROAD CITY: BHAT, AHMEDABAD STATE: K7 ZIP: 382 210 BUSINESS PHONE: 91-2718-225001 MAIL ADDRESS: STREET 1: SARKHEJ-DHOLKA ROAD CITY: BHAT, AHMEDABAD STATE: K7 ZIP: 382 210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cadila Pharmaceuticals Ltd CENTRAL INDEX KEY: 0001461239 STATE OF INCORPORATION: K7 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 14711352 BUSINESS ADDRESS: STREET 1: SARKHEJ-DHOLKA ROAD CITY: BHAT, AHMEDABAD STATE: K7 ZIP: 382 210 BUSINESS PHONE: 91-2718-225001 MAIL ADDRESS: STREET 1: SARKHEJ-DHOLKA ROAD CITY: BHAT, AHMEDABAD STATE: K7 ZIP: 382 210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-03-12 1 0001000694 NOVAVAX INC NVAX 0001461239 Cadila Pharmaceuticals Ltd CADILA CORPORATE CAMPUS, SARKHEJ- DHOLKA ROAD BHAT, AHMEDABAD GUJARAT K7 382 210 INDIA 0 0 1 0 0001461647 Satellite Overseas (Holdings) Ltd 7 HILL STREET, DOUGLAS ISLE OF MAN E9 1M1EF CAYMAN ISLANDS 0 0 1 0 Common Stock 2014-03-19 4 S 0 1000000 5.17 D 11500000 I See footnote Common Stock 2014-03-20 4 S 0 1000000 4.99 D 10500000 I See footnote Common Stock 2014-03-21 4 S 0 1000000 4.69 D 9500000 I See footnote The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.07 to $5.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.87 to $5.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.47 to $4.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These shares are owned directly by Satellite Overseas (Holdings) Limited, which is a wholly owned subsidiary (except for directors' qualifying shares) of Cadila Pharmaceuticals Ltd. Cadila Pharmaceuticals Ltd is an indirect beneficial owner of the reported securities. These shares are held for convenience in the name of "SOHL, Inc., as nominee for Satellite Overseas (Holdings) Limited." SOHL, Inc., has no voting, dispositive or pecuniary interest in any such shares. /s/ Dr. Rajiv I. Modi of Cadila Pharmaceuticals Ltd 2014-03-21 EX-99 2 attachment1.htm EX-99 DOCUMENT

                                                                      EXHIBIT 99

FORM 4 JOINT FILER INFORMATION

Name:                      Satellite Overseas (Holdings) Limited
Address:                   7 Hill Street, Douglas, Isle of Man, 1M1EF
Designated Filer:          Cadila Pharmaceuticals Ltd
Issuer and Ticker Symbol:  Novavax, Inc. [NVAX]

Date of Event Requiring Statement:     March 21, 2014


Signature:
Satellite Overseas (Holdings) Limited

By: /s/ Rajiv I. Modi
    ---------------------
Name:   Dr. Rajiv I. Modi
Title:  Director